Wanguang Zhang, M.D.
Tongji Hospital
3
2
0
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+5 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Liangrong Shi, M.D.
Xiangya Hospital of Central South University
Shared therapeutic areas:
Salah-Eddin Al-Batran, Prof. Dr.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Shared therapeutic areas:
Kangshun Zhu, MD
Second Affiliated Hospital of Guangzhou Medical University
Shared therapeutic areas:
Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Yan Sun, MD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Roxana S. Dronca, MD
Mayo Clinic
Shared therapeutic areas:
Tsang-Wu Liu
Taiwan Cooperative Oncology Group, NHRI
Shared therapeutic areas:
Kangshun Zhu, Dr.
Second Affiliated Hospital of Guangzhou Medical University
Shared therapeutic areas:
Hao Feng, MD., Ph.D.
Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU
Shared therapeutic areas:
Shuhang Wang
NCC, CICAMS
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
GNB4 and Riplet Gene Methylation Combined Detection Kit for Hepatocellular Carcinoma Recurrence Monitoring
All 3 trials loaded